This information was published on 2021-12-31T00:18:22 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2220753 |
| (220) |
18 Oct 2021
|
| (300) |
GB, 30 Jul 2021, 3675692
|
| (511) (510) |
Class 5
Pharmaceutical and medicinal preparations and substances; vaccines |
| (540) | RESVIQ |
| (550) | Word |
| (730) |
GlaxoSmithKline Biologicals SA
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.